中融信託與建信信託及中信信託簽訂託管協議
中融信託公布,受內外部多重因素影響,公司部分信託產品無法按期兌付。為提升公司經營管理效能,經股東會授權、董事會審議通過,公司與建信信託、中信信託簽訂《委託管理服務協議》,聘請兩家公司為中融信託經營管理提供專業服務。
資料顯示,於2010年,經緯紡機(000666.SZ)受讓中植集團持有的中融信託1.17億股股份,成為其第一大股東。2022年年報顯示,經緯紡機持股37.47%,中植集團有限公司持股32.99%。經緯紡機公布,主動撤回A股股票在深所上市交易的議案獲臨時股東大會批准。退市後將申請在全國中小企業股份轉讓系統轉讓。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.